Home › Schizophrenia › California › Torrance
Schizophrenia clinical trials in Torrance, CA
6 studies for Schizophrenia are looking for participants at sites in and around Torrance (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia
RecruitingPhase 3
- Local Institution - 0193, Torrance
NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia
RecruitingPhase 3
- Neurocrine Clinical Site, Torrance
Efficacy of NBI-1117568 in Preventing Relapse in Adults With Schizophrenia
RecruitingPhase 3
- Neurocrine Clinical Site, Torrance
A Study of Brenipatide in Adult Participants With Schizophrenia
RecruitingPhase 2
- Collaborative Neuroscience Research, LLC, Torrance
A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia
RecruitingPhase 2
- Clinical Site, Torrance
NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia
RecruitingPhase 3
- Neurocrine Clinical Site, Torrance
About Schizophrenia
Schizophrenia is a serious brain illness that can include hearing voices that aren't there and thinking others are trying to hurt them.
More about Schizophrenia on MedlinePlus
Schizophrenia trials in other cities
- Atlanta, GA22 studies
- Chicago, IL21 studies
- Little Rock, AR19 studies
- Hollywood, FL15 studies
- Boston, MA14 studies
- Houston, TX13 studies
- San Diego, CA13 studies
- Hialeah, FL13 studies
- New York City, NY13 studies
- Austin, TX13 studies
- Garden Grove, CA12 studies
- Germantown, MD11 studies
Other studies in Torrance
- Non-Small Cell Lung Cancer11 studies
- Obesity9 studies
- Overweight9 studies
- Breast Cancer9 studies
- Bladder Cancer7 studies
- Lung Cancer7 studies
- Cardiovascular Disease7 studies
- Heart Failure5 studies
- Atherosclerosis5 studies
- Metastatic Cancer4 studies
- Colorectal Cancer4 studies
- Coronary Artery Disease4 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.